Established in 2015, the Center for Vaccines and Immunology (CVI) provides an environment for world-class research and training in immunology. The CVI is advancing fundamental and translational immunological knowledge to develop new vaccines and therapies for infectious diseases and other immunity-related diseases and syndromes.
Infographic with Center for Vaccines & Immunology (CVI) surrounded by 5 main goals of center activity
UGA’s collaborative research explores the mystery of Influenza B, tracking the Victoria and Yamagata lineages to improve vaccine design and predict the virus’s future evolutionary path.
Assessment of immunogenicity and protection induced by COBRA HA vaccines formulated with Infectimune in young and elderly ferrets
PLoS One. February 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral function
Cell Rep. January 2026
Elicitation of Protective Immune Responses Against Influenza Virus Following Intranasal Delivery of Fluzone or Flublok Vaccines
Vaccines (Basel). January 2026
Protective efficacy of a ‘pan-fungal’ vaccination strategy against experimental Pneumocystis infection in drug-immunosuppressed macaques
Front Immunol. January 2026
Delineation of the antibody light chain biases and kinetics following primary and secondary influenza virus infections of ferrets
Immunohorizons. January 2026
Influenza hemagglutinin and neuraminidase multivalent vaccine elicits broader protective immune responses compared to vaccine formulations composed of hemagglutinin and neuraminidase
Hum Vaccin Immunother. December 2025
